Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2019

View Archived Issues

New mouse model for intrahepatic cholangiocellular carcinoma reveals protective effect of Pecam-1

Signaling promotes glucose uptake, brain tumor development

Novel Dyrk1 inhibitor DYR-219 delays the onset of AD-like pathology in 3xTg-AD mice

Artesunate modifies T cells to protect against type 1 diabetes

SNP-162 inhibits growth of sorafenib-resistant liver cancer cell lines

CStone completes registration filing in Australia for phase I trial of CS-3002 in solid tumors

NO-releasing polymer NVN-1000 inhibits HPV DNA replication and progeny virus production

MEIS2 knockdown prevents colorectal cancer cell migration and invasion

Monoclonal antibody P52E03 protects against H7N9 virus challenge

Transgenic expression of human STING mutant in hematopoietic cells provides murine SAVI model

Enrollment ongoing in phase II study of osilodrostat in pediatric patients with Cushing's disease

FIAsp receives European approval for the management of diabetes in adolescents and children

Tanabe initiates first-in-human study of TR1801-ADC

Off-target resistance to TRK inhibitors

Sunshine Lake Pharma describes new farnesoid X receptor agonists

Otago Innovation, University of Copenhagen patent CaMK2A ligands

Anhui New Star Pharmaceutical Development discovers P2Y12 antagonists

New IDO-1 inhibitors identified at Hinova Pharmaceuticals

Boehringer Ingelheim presents ghrelin O-acyltransferase inhibitors

Daewoong's pulmonary fibrosis drug DWN-12088 enters global phase I trial

Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...